150 related articles for article (PubMed ID: 17519149)
1. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception.
Beksinska ME; Kleinschmidt I; Smit JA; Farley TM
Contraception; 2007 Jun; 75(6):438-43. PubMed ID: 17519149
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.
Beksinska ME; Kleinschmidt I; Smit JA; Farley TM
Contraception; 2009 May; 79(5):345-9. PubMed ID: 19341845
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
Wanichsetakul P; Kamudhamas A; Watanaruangkovit P; Siripakarn Y; Visutakul P
Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status.
Beksinska ME; Kleinschmidt I; Smit JA
Womens Midlife Health; 2018; 4():6. PubMed ID: 30766716
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
Beksinska ME; Kleinschmidt I; Smit JA; Farley TM; Rees HV
Contraception; 2009 Aug; 80(2):128-32. PubMed ID: 19631787
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Milford C; Farley TM
Contraception; 2010 Jan; 81(1):30-4. PubMed ID: 20004270
[TBL] [Abstract][Full Text] [Related]
8. Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM
S Afr Med J; 2011 Feb; 101(2):131-5. PubMed ID: 21678742
[TBL] [Abstract][Full Text] [Related]
9. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.
Cromer BA; Bonny AE; Stager M; Lazebnik R; Rome E; Ziegler J; Camlin-Shingler K; Secic M
Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431
[TBL] [Abstract][Full Text] [Related]
11. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
12. Long-term depot-medroxyprogesterone acetate and bone mineral density.
Tang OS; Tang G; Yip P; Li B; Fan S
Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
[TBL] [Abstract][Full Text] [Related]
13. Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate.
Beksinska ME; Smit JA; Kleinschmidt I; Rees HV; Farley TM; Guidozzi F
Contraception; 2003 Nov; 68(5):339-43. PubMed ID: 14636937
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
Clark MK; Sowers MR; Nichols S; Levy B
Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
[TBL] [Abstract][Full Text] [Related]
16. A prospective, controlled study of the effects of hormonal contraception on bone mineral density.
Berenson AB; Radecki CM; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2001 Oct; 98(4):576-82. PubMed ID: 11576570
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
[TBL] [Abstract][Full Text] [Related]
18. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women.
Tharnprisarn W; Taneepanichskul S
Contraception; 2002 Aug; 66(2):101-3. PubMed ID: 12204782
[TBL] [Abstract][Full Text] [Related]
20. Forearm bone density in users of Depo-Provera as a contraceptive method.
Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
